Regulatory tailwinds and weak earnings set the stage The FDA's draft guidance to speed approval of genome editing and RNA therapies has put CRISPR Therapeutics (CRSP) in focus, even as the company ...

The FDA has issued draft guidance that could speed up approval pathways for rare disease therapies using genome editing technologies. This framework is directly relevant to CRISPR Therapeutics, which ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...

CRISPR Therapeutics AG CRSP shares jumped on Thursday, building on its Feb. 13 earnings report that showed growing momentum ...

Chinese scientists at Xianghu Laboratory used CRISPR/Cas9 to create popcorn-like aromatic tomatoes by silencing SlBADH1 and ...

After a three-month hiatus, Watson Season 2 is back with The Tunnel Under the Elms this Sunday. Watch an exclusive sneak peek here!

Centessa Pharmaceuticals is developing a medicine called ORX750 for narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and ...

A research team led by Professor Ki-Young Lee at the College of Medicine, Sungkyunkwan University, has uncovered a previously unrecognized tumor-intrinsic role of the immune checkpoint molecule PD-L1, ...

Scientists generate world’s first ’extraordinary aromatic tomato plants’ by simultaneously altering two key genes ...